Cresti, Laura
Falciani, Chiara
Cappello, Giovanni
Brunetti, Jlenia
Vailati, Silvia
Melloni, Elsa
Bracci, Luisa
Pini, Alessandro
Article History
Received: 24 June 2022
Accepted: 7 November 2022
First Online: 11 November 2022
Competing interests
: The peptide SET-M33 is covered by a patent owned by the University of Siena and licensed to SetLance srl. Chiara Falciani, Alessandro Pini and Luisa Bracci are partner of SetLance. The rest of authors declare that they have no other competing financial interests.